Alembic Pharmaceuticals Limited — Board Meeting, 03-02-2025: Outcome of Board Meeting

The Board of Directors of Alembic Pharmaceuticals Limited has approved the unaudited financial results for the quarter and nine months period ended 31st December 2024. The consolidated revenue from operations stands at ₹1,692.74 Cr, with a total income of ₹1,702.25 Cr. The company reported a profit before tax of ₹177.78 Cr and a net profit of ₹140.46 Cr after accounting for tax expenses. Additionally, the Board has appointed Ms. Geeta Goradia as an Independent Director for five years, contingent upon approval via a special resolution.